We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HRMY market cap is 1.97B. The company's latest EPS is USD 2.2593 and P/E is 15.27.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 160.27M | 168.41M | 154.62M | 172.81M | 186.04M |
| Operating Income | 64.36M | 40.2M | 52.03M | 21.36M | 61.71M |
| Net Income | 38.46M | 26.61M | 38.33M | 11.36M | 46.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6M | 159.74M | 305.44M | 437.86M | 582.02M |
| Operating Income | -145.9M | 16.99M | 87.53M | 120.19M | 192.03M |
| Net Income | -187.21M | -63.85M | 34.6M | 181.47M | 128.85M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 777.77M | 811.45M | 846.99M | 858.38M | 928.14M |
| Total Liabilities | 296.43M | 344.46M | 331.59M | 319.8M | 331.33M |
| Total Equity | 481.33M | 466.99M | 515.39M | 538.58M | 596.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.7M | 427.07M | 433.44M | 673.87M | 811.45M |
| Total Liabilities | 118.29M | 329.89M | 246.94M | 271.03M | 344.46M |
| Total Equity | -422.86M | 97.18M | 186.51M | 402.84M | 466.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 142.72M | 219.39M | 31.14M | 73.76M | 144.26M |
| Investing | -10.37M | -46.44M | -6.19M | -61.04M | -60.3M |
| Financing | -52.03M | -105.55M | -3.63M | -7.08M | -8.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.44M | -2.99M | 98.56M | 144.47M | 219.39M |
| Investing | -127.15M | -2M | -100.3M | -141.83M | -46.44M |
| Financing | 143.77M | 209.16M | 7.42M | 6.84M | -105.55M |
| Market Cap | 1.97B |
| Price to Earnings Ratio | 15.27 |
| Price to Sales Ratio | 3.38 |
| Price to Cash Ratio | 6.31 |
| Price to Book Ratio | 4.21 |
| Dividend Yield | - |
| Shares Outstanding | 57.03M |
| Average Volume (1 week) | 347.45k |
| Average Volume (1 Month) | 544.58k |
| 52 Week Change | 5.80% |
| 52 Week High | 41.61 |
| 52 Week Low | 28.14 |
| Spread (Intraday) | 0.77 (2.21%) |
| Company Name | Harmony Biosciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harmonybiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
